The ENTPD1 promoter polymorphism −860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk

Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty

(2013) David R. Anderson et al.   ANNALS OF INTERNAL MEDICINE

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls

(2013) Benedetto Simone et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

A Genome-Wide Association Study for Venous Thromboembolism: The Extended Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium

(2013) Weihong Tang et al.   GENETIC EPIDEMIOLOGY

Influence ofCYP2C8*2on the Pharmacokinetics of Pioglitazone in Healthy African-American Volunteers

(2013) Christina L. Aquilante et al.   PHARMACOTHERAPY

Mechanistic View of Risk Factors for Venous Thromboembolism

(2012) Pieter H. Reitsma et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q

(2012) J. A. HEIT et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism

(2012) Timothy A. Brighton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin for Preventing the Recurrence of Venous Thromboembolism

(2012) Cecilia Becattini et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension

(2011) James P. Maloney et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Long-term Management of Venous Thromboembolism

(2011) Kenneth A. Bauer   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Chronic Thromboembolic Pulmonary Hypertension

(2011) Gregory Piazza et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetics of Venous Thrombosis: Insights from a New Genome Wide Association Study

(2011) Marine Germain et al.   PLoS One

Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype

(2010) K. M. Dwyer et al.   AMERICAN JOURNAL OF TRANSPLANTATION

cAMP/CREB-mediated Transcriptional Regulation of Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39) Expression

(2010) Hui Liao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism

(2010) G. ANTONI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach

(2009) D.-A. Tregouet et al.   BLOOD

CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease

(2009) D. J. Friedman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Functional ENTPD1 Polymorphisms in African Americans With Diabetes and End-Stage Renal Disease

(2008) D. J. Friedman et al.   DIABETES

Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs

(2008) Jörg Reutershan et al.   FASEB JOURNAL

Gene Variants Associated With Deep Vein Thrombosis

(2008) Irene D. Bezemer   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ecto-nucleoside Triphosphate Diphosphohydrolase 1 (E-NTPDase1/CD39) Regulates Neutrophil Chemotaxis by Hydrolyzing Released ATP to Adenosine

(2008) Ross Corriden et al.   JOURNAL OF BIOLOGICAL CHEMISTRY